Funding for this research was provided by:
National Institutes of Health (R01ES027595 and S10OD020025, R01CA199376, K01DK116917, F31CA236405, DK43351, AT009708 and AI137325, T32GM007752)
China Sponsorship Council
European Research Council (833247, FP/2007-2013/ERC grant 2012-322698, 948207)
Spinoza Grant of the Netherlands Organization for Scientific Research (NWO SPI 94-212)
IN-CONTROL CVON (CVON2012-03)
NWO Spinoza prize (NWO SPI 92-266)
Radboud University Medical Centre Hypatia Grant
Helmholtz-Zentrum für Infektionsforschung GmbH (HZI)
Received: 15 January 2021
Accepted: 21 June 2021
First Online: 6 July 2021
: The HFGP study was approved by the ethical committee of Radboud University Nijmegen (no. 42561.091.12). Experiments were conducted according to the principles expressed in the Declaration of Helsinki. Written informed consent was obtained from all participants.
: Not applicable.
: The authors declare that they have no competing interests.